IPS is an Oxford-based HealthTech company specializing in identifying and engaging global HCPs from the Rare Diseases Sector, gathering insights and knowledge that enables clients to develop clinical and commercial strategies and build unique and long-term digital relationships. IPS’s renowned team of international scientists, medics, compliance, and technical experts manage all aspects of insight gathering and HCP engagement initiatives, providing clients with an end-to-end solution.
There is no investment information
No recent news or press coverage available for IPS.